SILVERARC CAPITAL MANAGEMENT, LLC Seres Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$2.35M
portfolio value

SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+87.17%
quarter

Seres Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +5.39% 18.73K shares 1.16M $6.42 366.49K
Q2 2022 share Increase +6.39% 20.88K shares -1.13M $3.43 347.76K
Q1 2022 share Increase +1.96% 6.27K shares -344K $7.12 326.87K
Q4 2021 share Increase +16.65% 45.76K shares 758K $8.55 320.60K
Q3 2021 call Decrease -100.00% -122.7K shares -2.92M $6.96 0
Q3 2021 share Increase +330.00% 210.91K shares 389K $6.96 274.83K
Q2 2021 call Increase 0.00% 122.7K shares 2.92M $23.85 122.7K
Q2 2021 share Decrease -36.09% -36.08K shares -535K $23.85 63.91K
Q1 2021 share Increase +300.00% 75K shares 1.44M $20.59 100K
Q4 2020 share Increase 0.00% 25K shares 613K $24.5 25K